2015
The impact of electroconvulsive therapy on the tryptophan–kynurenine metabolic pathway
Guloksuz S, Arts B, Walter S, Drukker M, Rodriguez L, Myint A, Schwarz M, Ponds R, van Os J, Kenis G, Rutten B. The impact of electroconvulsive therapy on the tryptophan–kynurenine metabolic pathway. Brain Behavior And Immunity 2015, 48: 48-52. PMID: 25765557, DOI: 10.1016/j.bbi.2015.02.029.Peer-Reviewed Original ResearchConceptsTrp-Kyn pathwayHamilton Depression Rating Scale-17 itemsElectroconvulsive therapyBeck Depression InventoryMechanism of actionKynurenic acidTrp-KynKyn/Trp ratioKYNA/KYN ratioTryptophan-kynurenine metabolic pathwayLast ECT sessionBilateral electroconvulsive therapyKyn/TrpTreatment of depressionMultilevel linear regression analysesKYN metabolitesECT sessionsAntidepressant effectsECT responseBipolar depressionECT treatmentTrp ratioNeuroprotective propertiesKynurenine pathwayNeurotoxic processes
2011
P02-557 - Electroconvulsive therapy treated patients’ and their relatives’ attitudes toward electroconvulsive therapy
Saran O, Celik S, Guloksuz S, Cakmak D. P02-557 - Electroconvulsive therapy treated patients’ and their relatives’ attitudes toward electroconvulsive therapy. European Psychiatry 2011, 26: 1153. DOI: 10.1016/s0924-9338(11)72858-9.Peer-Reviewed Original ResearchMini-Mental State ExaminationMental State ExaminationElectroconvulsive therapyMemory problemsSubjective feelingsState ExaminationBakirkoy ResearchNegative viewsSide effectsBenefits of ECTClinical Global Impression ScaleMechanism of ECTOverall perceptionAttitudesPerceptionSubjective side effectsCommon side effectsAttitudes of patientsEffective treatment optionGlobal Impression ScaleImpression ScaleInpatient unitECT sessionsTreatment optionsPsychiatric illness